Bonum Certa Men Certa

European Patents Found to be Invalid and Deemed Impotent in the Highest British Court (Again)

It's about the tadalafil generic

Just gimme the hands



Summary: "Just gimme the patent," says every greedy corporation looking to ban its competition (including generics) and facilitate monopoly pricing; the problem is, the EPO keeps granting invalid patents that take a lot of time and money to formally invalidate (in courts), as Actavis v ICOS has just shown

THE number of patents granted by the U.S. Patent and Trademark Office (USPTO) declined last year after certainty associated with these patents had declined and then number of patent lawsuits had totally collapsed. We now see something similar going on in Europe. Was it inevitable? Couldn't we learn from the mistakes of American lawmakers and USPTO officials?



We are pleased to see that IP Kat (Rose Hughes) has recently been covering some cases that relate to the European Patent Office (EPO). Hughes is doing an OK job without coming across as a patent extremist like the Bristows staff at IP Kat and yesterday she wrote this article about a (British) Supreme Court outcome. Yet another EPO-granted patent has been found to be nonsense:

This morning, the UK Supreme Court delivered its decision in Actavis v ICOS [2019] USKC 15, upholding the Court of Appeal's decision that ICOS's dosage regimen patent was obvious. In doing so, the Supreme Court (in a welcome change...) has followed the previous approach of the lower courts to the question of inventive step in both the UK courts and in the jurisprudence of the EPO.

The patent in question related to tadalafil (branded as CIALIS). Tadalafil is an orally administered drug for treating sexual dysfunction. Tadalafil works in a similar way to Pfizer’s famous blockbuster drug Viagra, but with fewer side effects. The original first medical use patent for tadalafil (EP 0740668, "Daugan") and its associated SPC have both expired. The latest decision related to ICOS's patent (EP 1173181) which claimed a particular dosage regime of tadalafil. Lilly is the exclusive licensee of the patent.

In an attempt to clear the market for their own tadalafil generic, Actavis brought revocation proceedings against the ICOS/Lilly patent. Actavis argued that the claims lacked novelty and inventive step in view of the original tadalafil patent ("Daugan"). The contentious claims related to a dose regime of up to 5mg tadalafil per day. The Court of Appeal, in overturning Mr Justice Birss' decision, found the patent invalid for lack of inventive step (Actavis v ICOS [2017] EWCA Civ 1671). Particularly, it was found that the claimed dose would have been obvious for the skilled person to try (IPKat post here).


Notice that first comment which asks: "Can every one of Lord Hodge's 9 factors be accommodated within Lord Hodge's exposition of the EPO's Problem and Solution Approach? If not all, which ones not?"

“Can every one of Lord Hodge's 9 factors be accommodated within Lord Hodge's exposition of the EPO's Problem and Solution Approach?”
      --Anonymous
Someone "from France" then added: "One important factor seems indeed to be missing, which is the "reasonable expectation of success", even though certain of the listed factors are usually considered for applying this factor. The reasoning that the clinical trial is somewhat a "one way street" (to use EPO standards) is not completely out of scope, but the specific dosage finding that has been identified for optimal effect could, in my view, not have been necessarily derived from this approach (the dosage plateau could not have been expected, considering it seems to necessarily imply some hindsight). I'm not sure I agree with the comment in the post that such a decision is welcome..., I can hardly consider a diverging view between the EPO and national courts to be welcome."

Another anonymous commenter quotes: "The original first medical use patent for tadalafil (EP 0740668, "Daugan") and its associated SPC have both expired."

Then comes the question (or questions): "Doesn't this mean it has already passed through clinical trials? By the courts' logic should a 5mg dose already be known? What have I missed?"

What about public interests as well? Either way, the court has trashed yet another European Patent. Will António Campinos get the message or just keep on lying about quality?

“I can hardly consider a diverging view between the EPO and national courts to be welcome.”
      --Anonymous
Freshfields Bruckhaus Deringer LLP's Laura Whiting and Paul Abbott wrote about it this morning (publication time), calling it "its second patent decision in 6 months" (so rarely do we get to see, at least at this level, just how awful the quality of patents has become).

We'll probably hear a lot more about it in days if not weeks to come.

Recent Techrights' Posts

GNU/Linux Distributions as "Appliances" and DRM Platforms (the Case of ChromeOS and SteamOS)
Is this what we envisioned in the 1980s and 90s?
Fulfilling the Site's Full Potential
We remain devoted to the aforementioned goal of posting more original material
Over at Tux Machines...
2 days' worth
Microsoft's Demise in the Global News Cycle is Rather Telling
It should be noted that Microsoft is, in general, no longer prominent or dominant in news headlines
 
Upcoming Talk by Dr. Richard Stallman: Large Language Models Are Not Artificial Intelligence
LLMs aren't truly intelligent and cannot quite grasp what they spew out
GulagTube is a Burning Platform (Exit YouTube, Invidious Won't Save Us From Google/Alphabet in the Long Run)
Alphabet Agency (Google) sees the future of video as a "skinnerbox" (running Android) that indoctrinates you like TikTok does
Gemini Migration and Backup Capsule (Archive)
At the end we'll end up with something a lot better than before and latency should be massively reduced
Links 01/10/2023: Science, Education, and pro-Russia Slovakia Leadership
Links for the day
IRC Proceedings: Sunday, October 01, 2023
IRC logs for Sunday, October 01, 2023
Links 01/10/2023: Climate, Patents, Programming, and More
Links for the day
Apple and Microsoft Problems
half a dozen links
Malware in the Ubuntu Snap Store, Thanks to Canonical Bloatware Mindset
Reprinted with permission from Ryan Farmer
Gemini Rising
There are 3523 capsules
Richard Stallman Gave a Talk Yesterday, Will Give Another Talk Today, and Will Give Two More Talks in Germany Later This Week
Those cover at least 2 different topics
Beware the Microsoft Sharks
We won't forgive and forget
IRC Proceedings: Saturday, September 30, 2023
IRC logs for Saturday, September 30, 2023
Don't be Afraid of the Command Line, It Might Even be a Friend
There's a tendency to think that only graphical interfaces were made to simplify usage, and any declarative interface is by design raw, inherently unfit for usage
One Positive Note About GNU/Linux Coverage in 2023 (Less Microsoft)
GNU/Linux users do not want this, with very rare exceptions
Snaps Were Never Good at Security, But the Media Coverage is Just Appalling
The media should focus on culling Windows, not making a huge fuss over minor things wrongly attributed to "Linux"
Better Footage of Richard Stallman's Talk Last Week: “Freedom in computing, forty years after starting to really protect it”
Richard Stallman speaks about the cancer situation early in his speech
Links 30/09/2023: A Government Shutdown and More Blizzard Layoffs
Links for the day
Links 30/09/2023: Bing Almost Offloaded Due to Failure/Losses, Nvidia Raided
Links for the day
A Lot of Technological 'Progress' Has Been Nothing But Buzzwords
Free software does not try to excite people people over nothing
Community is the Lifeblood of Freedom in the GNU/Linux World
Removing or undoing the "cancerd" (systemd) is feasible but increasingly difficult
Proprietary Software: Here Today, Gone Tomorrow
Proprietary software has an entirely different mindset, revolving around business models rather than science
Web Hostnames Down to Lowest Number in More Than 7 Years!
the number of hostnames is falling rapidly (they hide this by choosing logarithmic scale)
Over at Tux Machines...
2 days' worth
Richard Stallman Says He Will Probably Live Many More Years
"Richard Stallman has cancer. Fortunately it is slow-growing and manageable follicular lymphona, so he will probably live many more years nonetheless. But he now has to be even more careful not to catch Covid-19."
Quitting 'Clown Computing' and GAFAM is Only the Start
The Web and the Net at large became far too centralised
Stop Begging Companies That Don't Value Your Freedom to Stop Pushing You Around
That's not freedom
They Say Free Software is Like Communism When They, the Proprietary Software Giants, Constantly Pursue Government Bailouts (Subsidies From Taxpayers)
At the moment Ukraine is at most risk due to its dependence on Microsoft (inside its infrastructure)
Social Control Media Has No Future, It Was Always Doomed to Fail (Also Promoted Based on Lies)
Recent events, including developments at Twitter, meant that they lost a lot of their audience and then, in turn, sponsors/advertisers
The forbidden topics
There are forbidden topics in the hacker community
They're Been Trying to 'Kill' Richard Stallman for Years (by Mentally Tormenting Him)
Malicious tongue wanted to do him what had been done to Julian Assange
We Temporarily Have Two Gemini Capsules
They're both authentic and secure, but they're not the same
Consumerism is Lying and Revisionism
We need to reject these liars and charlatans
Links 30/09/2023: Open VFS Framework, CrossOver 23.5, Dianne Feinstein Dies
Links for the day
Security Leftovers
GNU/Linux, Microsoft, and more
Microsoft Down on the World Wide Web, Shows Survey
down by a lot in this category
IRC Proceedings: Friday, September 29, 2023
IRC logs for Friday, September 29, 2023
A Society That Fails Journalists Does Not Deserve Journalism
It's probably too later to save Julian Assange as a working publisher (he might never recover from the mental torture), but as a person and a father we can wish and work towards his release
Almost Nothing To Go With Your Morning's Cup Of Coffee
Newspaper? What newspaper?